Vivet Therapeutics
Gene therapy developer
Vivet Therapeutics has raised €83M across 2 funding rounds from 7 investors, most recently a round in Jan 2019. Based in Paris, France; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€83M
€82,500,000
Funding rounds
2
Investors
7
distinct backers
Active since
2017-05
latest 2019-01
Funding by year
EUR raised per yearVivet Therapeutics — funding by year — interactive chart.
Data table
| Vivet Therapeutics — funding by year | |
|---|---|
| 2017 | €38M |
| 2018 | €45M |
Signals
High confidenceRaise-next likelihood7
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Other | €45M | Pfizer Ventures | View deal → |
| 2017-05-04 | Series A | €38M | Columbus Venture Partners,HealthCap,Kurma Partners,Novartis Venture Fund,Roche Venture Fund,Ysios Capital | View deal → |
Investors
7Related news
Similar companies
same sector, similar size- Docly€54MFrance · Healthtech
- Voluntis€53MFrance · Healthtech
- CARMAT€85MFrance · Healthtech
- inotrem€58MFrance · Healthtech
- Stilla Technologies€67MFrance · Healthtech
- Moon Surgical€81MFrance · Healthtech
Global coverage: FundingData